Tarsus Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Tarsus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $99.5. The average 1-year stock price forecast is 34.26% higher than the current stock price, while the lowest is $84 (+13.35%) and the highest is $116 (+56.52%).

Price Target: $99.5 (+34.26%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$84	$99.5	$100	$116
Change	+13.35%	+34.26%	+34.93%	+56.52%

Analyst Ratings

The average analyst rating for Tarsus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	8	8	8	8	7	8
Buy	1	1	1	1	0	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	7	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mazahir Alimohamed Oppenheimer	Oppenheimer	Buy Maintains $100	Buy	Maintains	$100	+34.93%	Oct 2, 2026
Andrea Newkirk Goldman Sachs	Goldman Sachs	Buy Initiates $116	Buy	Initiates	$116	+56.52%	Sep 24, 2026
Jenna Davidner Barclays	Barclays	Buy Initiates $110	Buy	Initiates	$110	+48.43%	Sep 16, 2026
Dennis Ding Jefferies	Jefferies	Buy Reiterates $105	Buy	Reiterates	$105	+41.68%	Sep 8, 2026
Lachlan Hanbury Brown William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Aug 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

721.05M

from 451.36M

59.75%

from 451.36M

Revenue Next Year

927.25M

from 721.05M

28.60%

from 721.05M

EPS This Year

-5.77

from -1.59

EPS Next Year

-0.36

from -5.77

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	57.03M	25.82M	17.45M	182.95M	451.36M	721.05M
Revenue Growth	-	-54.73%	-32.42%	948.62%	146.71%	59.75%
Operating Income	-12.16M	-62.71M	-143.16M	-120.57M	-70.97M	-224.23M
Net Income	-13.83M	-62.09M	-135.89M	-115.55M	-66.42M	-218.46M
EPS	-	-	-	-	-1.59	-5.77
Free Cash Flow	-	-	-	-	-22.31M	-114.61M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	735.3M
Avg	721.1M
Low	706.5M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	62.9%
Avg	59.8%
Low	56.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-2.15
Avg	-5.77
Low	-11.63

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-